United States Contraceptives Devices Market Outlook 2031:
The United States contraceptives devices market size was valued at USD 4.56 Billion in 2022 and is projected to reach USD 7.66 Billion by 2031, expanding at a CAGR of 5.93% during the forecast period 2023 - 2031. The growth of the market is attributed to the reduced unplanned pregnancies and their consequences.
Contraceptives device aids in preventing pregnancy by using drugs or devices. It is also known as birth control and fertility control devices. Increasing use of contraceptives at home has improved health related outcomes. Robust government promotions and schemes for women and child health is driving the market growth.
These devices are used to prevent transfer of sexually transmitted diseases or infections. Contraceptive devices could be temporary or permanent and are available for both men as well as women. Condoms are most preferred contraceptive devices and hold a large market share in the world. Copper IUD is basically used by the women to avoid possible side effects.
Bayer HealthCare collaborated with 11 NGOs, which in turn, led to increase of its share in the contraceptives devices market. Every year on September 26, “World Contraception Day” is celebrated to increase awareness about contraceptive methods, and encourage young people to make right decision about their reproductive health.
Contraceptives Devices Market Trends, Drivers, Restraints, and Opportunities
- Increasing population is anticipated to drive the market growth during the forecast period.
- Rising use of contraception in young women is projected to boost the market growth in the coming years.
- Growing requirement for family planning is expected to spur the market growth during the forecast period.
- Increasing awareness of modern contraception is anticipated to drive the market growth during the forecast period.
- Rising higher educational attainment is anticipated to drive the market growth during the forecast period.
- Growing health issues associated with teenage pregnancies is projected to boost the market growth in the coming years.
- Rising use of oral pills to avoid unplanned pregnancy is projected to boost the market growth in the coming years.
- Lack of social acceptance is estimated to restrict the market growth.
- Increasing health risks by using contraceptive devices can restrain the market growth in the coming years.
- Availability of alternate contraceptive methods is estimated to restrict the market growth.
- Growing number of clinics in the contraceptive market can estimate the market growth.
- Increasing medical tourism in emerging nations is anticipated to create significant opportunities for the market players.
Scope of the Contraceptives Devices Market Report
The report on the United States contraceptives devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
United States Contraceptives Devices Market- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Types (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Device (IUD), and Others) and Gender (Mal, and Female)
|
|
Country Scope
|
The US
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Bayer Healthcare; Abbvie (Allergan PLC); Reckitt Benckiser Group plc; Cooper Surgical, Inc.; and Pregna International Limited
|
United States Contraceptives Devices Market Segment Insights
Cervical caps segment to hold a significant market share
Based on types, the Unites States contraceptives devices market is divided into condoms, diaphragms, cervical caps, sponges, vaginal rings, intra uterine device (IUD), and others.
The diaphragms segment is anticipated to hold a key share of the market in the coming years due to portability and reusability. However, the caps segment is anticipated to expand at a rapid pace during the forecast period, as it keeps sperm from entering the uterus and fallopian tubes.
Female segment is anticipated to hold a large market share
On the basis of gender, the United States contraceptives devices market is segmented into male and female. The male segment is projected to constitute a major market share during the forecast period due to its cost-effectiveness than female contraceptive devices.
On the other hand, the female segment is anticipated to expand at a rapid pace during the forecast period owing to reducef risk of uterine cancer, and regulates menstrual cycles and makes periods less painful.
Segments
The United States contraceptives devices market has been segmented on the basis
Types
- Condoms
- Diaphragms
- Cervical Caps
- Sponges
- Vaginal Rings
- Intra Uterine Device (IUD)
- Others
Genders
Country
Key Players
Competitive Landscape
Key players competing in the United States contraceptives devices market includes Bayer Healthcare; Abbvie (Allergan PLC); Reckitt Benckiser Group plc; Cooper Surgical, Inc.; and Pregna International Limited.
Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.
In India, Durex a Britain brand introduced a new product range, ‘‘Durex invisible condoms’’ in October 2020 as India’s thinnest product.
Request For Customization
Enquiry Before Buying
Speak With Analyst
